NCT06908304
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06908304
Title A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Maia Biotechnology
Indications
Therapies
Age Groups: adult | senior
Covered Countries TUR | ROU | POL

Facility Status City State Zip Country Details
Centrum Medyczne Pratia RECRUITING Poznan Poland Details
Oncolab S.R.L. RECRUITING Craiova Romania Details
Spitalul Clinic Municipal de Urgenta Timisoara/ Clinica de Oncologie Medicala RECRUITING Timișoara Romania Details
Changhua Christian Hospital (CCH) RECRUITING Changhua Taiwan Details
Taipei Tzu Chi Hospital RECRUITING Chiayi City Taiwan Details
Chang-Gung Memorial Hospital - KaoHsiung RECRUITING Kaohsiung City Taiwan Details
Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) RECRUITING Kaohsiung City Taiwan Details
Chung Shan Medical University Hospital (CSMUH) RECRUITING Taichung Taiwan Details
Taipei Medical University Hospital (TMUH) RECRUITING Taipei Taiwan Details
Tri-Service General Hospital RECRUITING Taipei Taiwan Details
Chang-Gung Memorial Hospital - Linko RECRUITING Taoyuan Taiwan Details
Medicalpark Hastanesi RECRUITING Adana Turkey (Türkiye) Details
Liv Hospital RECRUITING Ankara Turkey (Türkiye) Details
Göztepe Süleyman Yalçın Şehir Hastanesi RECRUITING Istanbul Turkey (Türkiye) Details
İstinye University RECRUITING Istanbul Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field